Mi‐Jeong Kim
- Aging top 2%
- Infectious Diseases top 2%
- Immunology top 5%
- Pharmacology top 1%
- Epidemiology top 2%
-
- Chemical Synthesis and Analysis 9
-
- Alzheimer's disease research and treatments 9
-
- Endoplasmic Reticulum Stress and Disease 8
-
- Cardiac Valve Diseases and Treatments 6
-
- NF-κB Signaling Pathways 6
-
- Drug Transport and Resistance Mechanisms 5
-
- Asymmetric Synthesis and Catalysis 5
-
- Vector-borne infectious diseases 5
- Co-authors
- David G. RussellPère-Joan CardonaSophie Allain‐MailletFrédéric AltareYoo‐Hyun LeeHo‐Geun YoonWoo Jin JunThomas Serwold
- Cited by
- AgingInfectious DiseasesImmunology
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Mi‐Jeong Kim
84 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Aging 121
- Infectious Diseases 887
- Immunology 674
- Pharmacology 272
- Epidemiology 1.0k
Countries citing papers authored by Mi‐Jeong Kim
This map shows the geographic impact of Mi‐Jeong Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi‐Jeong Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi‐Jeong Kim more than expected).
Fields of papers citing papers by Mi‐Jeong Kim
This network shows the impact of papers produced by Mi‐Jeong Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi‐Jeong Kim. The network helps show where Mi‐Jeong Kim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mi‐Jeong Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 6 | |
| 5 | 2020 | 5 | |
| 6 | 2019 | 6 | |
| 7 | 2015 | 76 | |
| 8 | 2015 | 27 | |
| 9 | 2010 | 13 | |
| 10 | 2010 | 31 | |
| 11 | 2009 | 200 | |
| 12 | 2009 | 261 | |
| 13 | 2009 | 132 | |
| 14 | 2009 | 37 | |
| 15 | 2008 | 6 | |
| 16 | 2007 | 249 | |
| 17 | Is it possible to Predict the Progression Rate in Korean IgA Nephropathy Patient | 2006 | 1 |
| 18 | 2006 | 16 | |
| 19 | Clinical Significance of Cystoscopy in the Evaluation of Isolated Asymptomatic Microscopic Hematuria | 2005 | 0 |
| 20 | Differentially Expressed Antigens of Orientia tsutsugamushi Revealed by Monoclonal Antibodies | 2005 | 1 |
About Mi‐Jeong Kim
Mi‐Jeong Kim is a scholar working on Aging, Applied Microbiology and Biotechnology and Nephrology, having authored 88 papers that have together received 4.6k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (9 papers), Alzheimer's disease research and treatments (9 papers), Endoplasmic Reticulum Stress and Disease (8 papers), Cardiac Valve Diseases and Treatments (6 papers), NF-κB Signaling Pathways (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Asymmetric Synthesis and Catalysis (5 papers) and Vector-borne infectious diseases (5 papers). The work is most often cited by research in Aging (121 citations), Infectious Diseases (887 citations) and Immunology (674 citations). Mi‐Jeong Kim has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include David G. Russell, Père-Joan Cardona, Sophie Allain‐Maillet, Frédéric Altare, Yoo‐Hyun Lee, Ho‐Geun Yoon, Woo Jin Jun, Thomas Serwold, Jong‐Min Song and Jae‐Kwan Song. Their work appears in journals such as Cell, Angewandte Chemie International Edition and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.